Francis Medical

Francis Medical Francis Medical is a dynamic medical device company committed to developing urological cancer treatment. Our Mission Is to Be:
Tough on Cancer. With U.S.

Gentle on Patients. Francis Medical develops innovative medical technologies to treat urological cancers while remaining gentle on patients. Our first product, the FDA-cleared Vanquish® Water Vapor Ablation System, uses the natural energy stored in sterile water vapor to ablate targeted prostate tissue through a minimally invasive, transurethral procedure. Our mission is personal. The company is n

amed in memory of Founder Michael Hoey’s father, Francis, who lost his life to prostate cancer in 1991. Inspired by his story, we are committed to creating technologies that help patients avoid the life-altering side effects often associated with traditional prostate cancer therapies. We believe in solutions that help patients quickly return to their normal lives. clearance achieved and international regulatory pathways underway, we are focused on bringing this breakthrough therapy to more people around the world. Follow us for updates, clinical insights, and news about our ongoing mission to improve cancer care.

04/28/2026

🎗️ April is Cancer Prevention and Early Detection Month

This month is dedicated to raising awareness about the importance of cancer prevention and early detection across all cancer types. Routine screening can play an important role in identifying disease earlier, when more care options may be available.

For prostate health specifically, screening decisions are personal and should be made in consultation with a qualified physician, based on individual risk factors.

Routine cancer screening is an important part of staying well. Take charge of your health today and encourage those around you to do the same by signing up for screening reminders from Earl E. Bird: preventcancer.org/add-cancer-screening-reminder/

Francis Medical is a medical device company focused on developing urological cancer treatments designed to prioritize patient care. Learn more: francismedical.com

Rx Only. FDA Cleared. See francismedical.com for safety information.

04/23/2026

Celebrating 8 years of Francis Medical 🎉

Our mission is to be: Tough on Cancer, Gentle on Patients

That mission is deeply personal. In 1991, Francis Hoey, father of our founder, Michael Hoey, passed away due to prostate cancer complications following treatment that led to debilitating side effects. Experiencing those challenges firsthand shaped a vision grounded in the belief that there must be a better way forward.

Francis Medical was founded on that conviction, bringing together deep expertise in urology and anatomy, a passion to improve what’s possible for men diagnosed with prostate cancer, and a drive for innovation inspired by high-performance engineering.

Eight years later, we remain committed to advancing this mission alongside the clinicians, partners, and patients who continue to shape our journey.

Learn more: francismedical.com

Thank you for being part of it. Here’s to what’s ahead. 💙

RX Only. FDA Cleared. See francismedical.com for safety information.

04/21/2026

🚀 As adoption continues to grow, we’re proud to announce the first commercial (non-clinical trial) procedure in the Midwest using the Vanquish® Water V***r Ablation System.
The procedure was performed by Aaron Milbank, MD, of Minnesota Urology at High Pointe Surgery Center in Lake Elmo, Minnesota, marking the first use of the Vanquish System in routine clinical practice in the region.

Developed by Francis Medical, the Vanquish System is designed to ablate targeted prostate tissue using high-energy sterile water v***r delivered via a transurethral approach.

Thank you to Dr. Milbank, Minnesota Urology, and High Pointe Surgery Center for their collaboration and leadership in bringing this innovation into routine clinical practice for select patients.
Congratulations to all involved in reaching this important milestone.

Read more: https://tinyurl.com/FirstInMidwest

Rx Only. FDA Cleared. See francismedical.com for safety information.

04/16/2026

🌊 Momentum continues to build for the Vanquish® Water V***r Ablation System with expanded commercial use in the Southern United States.

Recent procedures were successfully performed in Atlanta, Georgia, by Drs. Neal Patel and Jason Lomboy of Advanced Urology at Johns Creek Surgery Center and Marietta Surgery Center, respectively.

Developed by Francis Medical, the Vanquish System delivers high-energy sterile water v***r via a transurethral approach to ablate targeted prostate tissue.

Thank you to Dr. Patel, Dr. Lomboy, Advanced Urology, and the teams at Johns Creek and Marietta Surgery Centers for their leadership in advancing patient care.

Learn more: tinyurl.com/VanquishPR

Rx Only. FDA Cleared. See francismedical.com for safety information.

04/14/2026

Advantages of the Vanquish® Water V***r Ablation System

The Vanquish System provides targeted ablation of lesions in any location in the prostate.
➡️ Single modality that can treat anywhere in the prostate, including the apex, anterior, or in the transition zone
➡️ Transurethral delivery incorporating standard cystoscopy and TRUS
➡️ High patient satisfaction results
➡️ Low rates of urinary incontinence and erectile dysfunction

Explore these advantages and see results of the V***R 2 Study: francismedical.com/Vanquish

Rx Only. FDA Cleared. See francismedical.com for safety information.

04/09/2026

The EAU26 Prostate Cancer Run on March 14 brought the global urology community together for an early morning run and walk along the Thames in support of those impacted by prostate cancer. Proceeds from the event support the work of Europa Uomo, including initiatives that highlight the role of physical activity for men living with the disease.

Thank you to the organizers, sponsors, and all who participated—clinicians, industry partners, patients, and families—for contributing to such a meaningful event. We were especially proud to see Francis Medical’s James Wright take part alongside so many dedicated individuals.

More about this amazing event: https://shorturl.at/P4TFX

💦 Explore Francis Medical’s work in urology: francismedical.com

RX Only. FDA Cleared. See francismedical.com for safety information.

Our Mission Is To Develop Therapies that Are: Tough on Cancer, Gentle on Patients.

European Association of Urology

04/07/2026

“We evaluate emerging technologies carefully to ensure they align with our clinical standards, safety, and patient-centered approach to deliver minimally invasive options supported by clinical evidence and responsible adoption.” — Dr. Rahul Mehan

At Francis Medical, advancing innovation starts with evidence. The clinical foundation behind the Vanquish® System reflects a commitment to safety, thoughtful adoption, and delivering meaningful outcomes for patients.

➡️ Explore the V***R 2 Study evidence and learn more in the press release: francismedical.com/evidence

Rx Only. FDA Cleared. See francismedical.com for safety information.
East Valley Urology Center

04/02/2026

The Vanquish® Water V***r Ablation System harnesses the Power of Phase Shift Energy, a breakthrough in targeted prostate tissue ablation.

💦 As water converts to v***r (or steam) at ~100°C, an exponential phase shift occurs, with the resulting water v***r carrying more than 5x the energy of water of the same mass.

The Vanquish® System is designed to use the phase shift energy stored in sterile water v***r to transfer thermal energy to targeted prostate tissue, causing cell death.

See the science behind this new ablation energy modality: francismedical.com/science

Rx Only. FDA Cleared. See francismedical.com for safety information.

03/31/2026

Looking back at the European Association of Urology Congress (EAU26), we’re grateful for the opportunity to connect with the urology community during an evening focused on advancing care.

Thank you to everyone who joined us for the dinner and presentation, and to Dr. Arvin George for sharing insights from the V***R 2 Study on patient experience. This novel, multi-center trial is evaluating the Vanquish® Water V***r Ablation System, a transurethral thermal water v***r approach to ablate prostate tissue, with data now reported on the first 110 patients at 12-month follow-up.

We appreciate the engagement and thoughtful discussion around emerging, evidence-based approaches to care.

🔎 Explore the evidence: francismedical.com/evidence

Rx Only. FDA Cleared. See francismedical.com for safety information.

***R2

03/25/2026

💦 We’re proud to celebrate the first Vanquish® procedure in routine commercial practice on the East Coast.

Performed by Dr. Robert Given of Urology of Virginia at Chesapeake Regional Surgery Center, this milestone reflects continued momentum as physicians bring this innovative, minimally invasive option into everyday practice.

Thank you to Dr. Given, Urology of VA, and Chesapeake Regional Surgery Center for advancing care and expanding access. Congratulations to all involved!

Learn more in the full press release: 👉 francismedical.com/news

Developed by Francis Medical, the Vanquish System is designed to ablate prostate tissue using high-energy sterile water v***r delivered via a transurethral approach.

Rx Only. FDA Cleared. See francismedical.com for safety information.

03/24/2026

“The patient satisfaction data further supports the exciting potential of the Vanquish technology,” said Dr. Arvin George, director of Prostate Cancer Programs at the Johns Hopkins Brady Urological Institute, and a V***R 2 co-principal investigator. “Most patients experienced no pain, quickly resumed daily activities, and indicated high rates of satisfaction with their procedure and decision at 12 months.”

Echoing V***R 2 Study results: 93% of patients were extremely satisfied or satisfied at 12 months, with minimal to no pain reported.

The Vanquish® System is cleared for thermal ablation of targeted prostate tissue via transurethral approach.

🔗 More: francismedical.com

Rx Only. FDA Cleared. See francismedical.com for safety information.

03/19/2026

“This breakthrough technology holds the promise of minimizing the life-altering side effects commonly encountered with conventional, more aggressive prostate treatments.”
— Dr. Christopher Dixon

💦 Water v***r technology is designed to ablate prostate tissue with the thermal energy stored in sterile water v***r. The Vanquish® Water V***r Ablation System delivers targeted applications of thermal energy using a transurethral procedure.

See the science behind this approach: francismedical.com/science/

Rx Only. FDA Cleared. See francismedical.com for safety information.

Address

7351 Kirkwood Lane North, Suite 130
Maple Grove, MN
55369

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17639510370

Website

Alerts

Be the first to know and let us send you an email when Francis Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Francis Medical:

Shortcuts

Share

Category

About Us

Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer, yet gentle on patients. Our work is fueled by a compassionate belief that cancer can be stopped with minimally invasive treatments. The company’s core values are Quality, Integrity, Innovation, Excellence, and Collaboration.

Prostate Cancer

Using a new platform to treat endourological cancers, water v***r technology, we’re developing a device for treating prostate cancer, the second most common cancer in American men. Currently available prostate cancer treatments often result in life-altering side effects such as urinary incontinence and erectile dysfunction. Water v***r technology is intended to result in minimal side effects, offering a distinct advantage over other treatments.

Francis Medical is named after Francis Hoey, the father of inventor and Francis Medical founder, Michael Hoey. In 1991, after undergoing prostate cancer treatments with debilitating effects on his daily living, Francis died from prostate cancer.